Recent Finacing
Recent Raise
Bonum Therapeutics develops allosterically regulated, conditionally active therapeutics that fuse an antibody-binding sensor domain to a therapeutic domain, initially advancing regulated immunocytokines (IL-12, IFN-alpha, TGF-beta) for immuno-oncology.
